Cargando…
Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
Autores principales: | Roncon, Loris, Zuin, Marco, Zuliani, Giovanni, Rigatelli, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676312/ https://www.ncbi.nlm.nih.gov/pubmed/33221521 http://dx.doi.org/10.1016/j.accpm.2020.11.003 |
Ejemplares similares
-
Ongoing trials on COVID-19 treatments: please, don’t forget Venous Thromboembolism!
por: Zuin, Marco, et al.
Publicado: (2021) -
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021) -
Age-adjusted d-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021) -
Fatigue as long-term consequence of ARDS in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021) -
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2020)